SCHEMBL5759348

SCHEMBL5759348

c1ccc(Nc2ccc3ncc(-c4ccccc4)nc3n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 10/20 0.53
PIK3CA P42336 7/20 0.53
MAPK8 P45983 6/20 0.53
MAPK9 P45984 6/20 0.53
MAPK10 P53779 6/20 0.53
MAPK14 Q16539 1/20 0.52
PDGFRB P09619 2/20 0.49
PDGFRA P16234 2/20 0.49
ABL1 P00519 2/20 0.44
YES1 P07947 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
ALPG P10696 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
NTRK1 P04629 1/20 0.44
PIM1 P11309 1/20 0.44
KDR P35968 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697024 0.90 MAPK1 (0.56) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL5757148 0.90 LMNA (0.52) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL6767084 0.90 PIK3CA (0.49) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL6765135 0.90 TP53 (0.50) MAPK1PIK3CAMAPK8MAPK9MAPK10
Hydrochloric Acid SCHEMBL5623610 0.89 MAPK1 (0.55) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL6762811 0.87 ABCG2 (0.51) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL5759397 0.87 NPC1 (0.57) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL5761732 0.87 ABCG2 (0.48) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL5757913 0.87 PIK3CA (0.54) MAPK1PIK3CAMAPK8MAPK9MAPK10
SCHEMBL6765837 0.87 ABCG2 (0.51) MAPK1PIK3CAMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1028729-B1 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ZENTARIS GMBH (DE) 2006-08-16 EP disclosed
US-6727252-B1 THE SERINE/THREONINE KINASE FAMILY INCLUDES MEMBERS THAT REGULATE CELL GROWTH, MIGRATION, DIFFERENTIATION, GENE EXPRESSION, MUSCLE CONTRACTION, GLUCOSE METABOLISM, CELLULAR PROTEIN SYNTHESIS, AND REGULATION OF THE CELL CYCLE ZENTARIS AG (DE) 2004-04-27 US disclosed
US-6180631-B1 PREVENTING AND TREATING SERINE/THREONINE PROTEIN KINASE-RELATED ABNORMAL CONDITIONS IN MAMMALS ASSOCIATED WITH AN ABERRATION IN A SIGNAL TRANSDUCTION PATHWAY SUCH AS CANCER OR A FIBROTIC DISORDER ASTA MEDICA AKTIENGESELLSCHAFT (DE) 2001-01-30 US disclosed
EP-1028729-A2 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ASTA Medica Aktiengesellschaft (DE) 2000-08-23 EP disclosed
WO-1999017759-A2 METHODS OF MODULATING SERINE/THREONINE PROTEIN KINASE FUNCTION WITH 5-AZAQUINOXALINE-BASED COMPOUNDS ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1999-04-15 WO disclosed